Published on in Vol 9, No 2 (2021): February

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/23548, first published .
WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial

WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial

WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pulmonary Disease in China: Retrospective Randomized Controlled Trial

New in JMIR mhealth: WeChat as a Platform for Baduanjin Intervention in Patients With Stable Chronic Obstructive Pu… https://t.co/3NA5AK2YTb

3:43 PM · Feb 02, 2021

0
0

Cookie Consent

We use our own cookies and third-party cookies so that we can show you this website and better understand how you use it, with a view to improving the services we offer. If you continue browsing, we consider that you have accepted the cookies.